TTK Healthcare Limited Asset Resilience Ratio

Latest as of March 2026: 68.81%

TTK Healthcare Limited asset resilience ratio. TTK Healthcare Limited (TTKHLTCARE) has an Asset Resilience Ratio of 68.81% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See TTK Healthcare Limited liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Liquid Assets

Rs9.14 Billion
≈ $98.88 Million USD Cash + Short-term Investments

Total Assets

Rs13.29 Billion
≈ $143.70 Million USD All company assets

Resilience Assessment

Very High
Financial Resilience Level

Asset Resilience Ratio of TTK Healthcare Limited (2005–2026)

Asset resilience ratio of TTK Healthcare Limited from 2005 to 2026. This chart shows how TTK Healthcare Limited's Asset Resilience Ratio has changed over time. Read TTKHLTCARE total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down TTK Healthcare Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is TTK Healthcare Limited's balance sheet.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Rs0.00 0%
Short-term Investments Rs9.14 Billion 68.81%
Total Liquid Assets Rs9.14 Billion 68.81%

Asset Resilience Insights

  • Very High Liquidity: TTK Healthcare Limited maintains exceptional liquid asset reserves at 68.81% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company has significant short-term investments, indicating active treasury management.

TTK Healthcare Limited Industry Peers by Asset Resilience Ratio

Compare TTK Healthcare Limited's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Merck & Company Inc
NYSE:MRK
Drug Manufacturers - General 0.22%
AstraZeneca PLC
NASDAQ:AZN
Drug Manufacturers - General 0.10%
Pfizer Inc
SA:PFIZ34
Drug Manufacturers - General 5.33%
Novartis AG
MX:NVSN
Drug Manufacturers - General 0.08%
Pfizer Inc
NYSE:PFE
Drug Manufacturers - General 5.33%
Novo Nordisk A/S
CO:NOVO-B
Drug Manufacturers - General 0.09%
Zhejiang Int'L Group Co Ltd
SHE:000411
Drug Manufacturers - General 0.00%
SANOFI CONS HEALTHC IND L
NSE:SANOFICONR
Drug Manufacturers - General 0.07%

TTK Healthcare Limited Asset Resilience Ratio by Year (2005–2026)

TTK Healthcare Limited asset resilience ratio by year from 2005 to 2026. The table below shows the annual Asset Resilience Ratio data for TTK Healthcare Limited.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2026-03-31 68.81% Rs9.14 Billion
≈ $98.88 Million
Rs13.29 Billion
≈ $143.70 Million
+2.77pp
2025-03-31 66.04% Rs8.46 Billion
≈ $91.50 Million
Rs12.81 Billion
≈ $138.56 Million
-3.72pp
2024-03-31 69.76% Rs8.38 Billion
≈ $90.57 Million
Rs12.01 Billion
≈ $129.84 Million
-1.80pp
2023-03-31 71.56% Rs8.37 Billion
≈ $90.56 Million
Rs11.70 Billion
≈ $126.54 Million
+25.35pp
2022-03-31 46.21% Rs2.58 Billion
≈ $27.92 Million
Rs5.59 Billion
≈ $60.40 Million
+2.19pp
2021-03-31 44.02% Rs2.18 Billion
≈ $23.53 Million
Rs4.94 Billion
≈ $53.45 Million
+15.28pp
2020-03-31 28.74% Rs1.24 Billion
≈ $13.40 Million
Rs4.31 Billion
≈ $46.63 Million
+1.19pp
2019-03-31 27.55% Rs1.15 Billion
≈ $12.39 Million
Rs4.16 Billion
≈ $44.97 Million
+5.79pp
2018-03-31 21.76% Rs886.21 Million
≈ $9.58 Million
Rs4.07 Billion
≈ $44.05 Million
+19.23pp
2017-03-31 2.53% Rs72.43 Million
≈ $783.27K
Rs2.86 Billion
≈ $30.98 Million
-0.82pp
2016-03-31 3.35% Rs101.34 Million
≈ $1.10 Million
Rs3.03 Billion
≈ $32.72 Million
+3.30pp
2015-03-31 0.05% Rs1.34 Million
≈ $14.46K
Rs2.75 Billion
≈ $29.76 Million
-0.01pp
2014-03-31 0.06% Rs1.34 Million
≈ $14.46K
Rs2.40 Billion
≈ $25.95 Million
-0.31pp
2013-03-31 0.37% Rs7.68 Million
≈ $83.07K
Rs2.09 Billion
≈ $22.64 Million
-2.80pp
2012-03-31 3.17% Rs67.68 Million
≈ $731.94K
Rs2.13 Billion
≈ $23.08 Million
-11.58pp
2011-03-31 14.75% Rs285.40 Million
≈ $3.09 Million
Rs1.93 Billion
≈ $20.92 Million
+0.98pp
2010-03-31 13.78% Rs212.75 Million
≈ $2.30 Million
Rs1.54 Billion
≈ $16.70 Million
+1.44pp
2009-03-31 12.34% Rs170.43 Million
≈ $1.84 Million
Rs1.38 Billion
≈ $14.94 Million
+2.11pp
2008-03-31 10.22% Rs121.77 Million
≈ $1.32 Million
Rs1.19 Billion
≈ $12.88 Million
+3.95pp
2007-03-31 6.27% Rs64.73 Million
≈ $700.08K
Rs1.03 Billion
≈ $11.16 Million
+1.72pp
2006-03-31 4.55% Rs41.65 Million
≈ $450.47K
Rs916.13 Million
≈ $9.91 Million
+0.33pp
2005-03-31 4.21% Rs39.17 Million
≈ $423.56K
Rs929.63 Million
≈ $10.05 Million
--
pp = percentage points

About TTK Healthcare Limited

NSE:TTKHLTCARE India Drug Manufacturers - General
Market Cap
$141.74 Million
Rs13.11 Billion INR
Market Cap Rank
#17689 Global
#942 in India
Share Price
Rs927.50
Change (1 day)
+1.28%
52-Week Range
Rs739.60 - Rs1191.00
All Time High
Rs1843.10
About

TTK Healthcare Limited engages in the animal welfare, consumer product, medical device, protective device, food, and other businesses in India. It operates through Animal Welfare, Consumer Products, Medical Devices, Foods, Protective Devices and Other segments. The Animal Welfare segment offers various feed supplements, liver correctives, fertility inducers, antibiotics, antiparasiticides, antisp… Read more